You are here: Industry Insights > Malaria

News List

Novartis reaches milestone delivery of 1 billion courses of antimalarial treatment worldpharmanews
May 20, 2021
Novartis announced that it has delivered one billion courses of antimalarial treatment since 1999. More than 90% of this artemisinin-based combination therapy (ACT) was supplied without profit to malaria-endemic countries around the globe.
Novel vaccination regimen shown to be effective in preventing malaria europeanpharmaceuticalreview
May 07, 2021
A three-dose regimen of Plasmodium falciparum sporozoites under chemoprophylaxis (PfSPZ-CVac) was shown to be safe, well tolerated and highly effective in a Phase II trial.
Novel vaccine 77 percent effective in preventing malaria, finds study europeanpharmaceuticalreview
April 28, 2021
The R21 vaccine candidate, when administered with 50mg of adjuvant, was found to be 77 percent effective in preventing malaria in children over 12 months.
Zydus announces completion of Phase-I trials of ZY19489 expresspharma
February 05, 2021
Zydus Cadila announced that its anti-malarial compound ZY19489 (MMV253) in development with Swiss-based product development partnership Medicines for Malaria Venture (MMV) has now completed Phase I clinical evaluation [Reg’n Number ACTRN12619000127101].
GSK, PATH, Bharat Biotech sign product transfer agreement for malaria vaccine expresspharma
January 28, 2021
Transfer builds on commitments to donate up to 10 million vaccine doses to the pilot implementation in regions of Ghana, Kenya, and Malawi and supply up to 15 million doses annually to 2028 if recommended for wider use.
Novartis, GSK team up for $3.6m genetic diversity research in Africa pharmaceutical-business-review
January 22, 2021
Swiss pharma giant Novartis and British pharmaceuticals company GSK have teamed up to conduct scientific research linking genetic diversity in Africa and its potential impact on response to drug therapeutics.
GSK, MMV filing for Kozenis in paediatric populations with P. vivax malaria accepted by Australian TGA pharmaceutical-business-review
January 14, 2021
GSK and Medicines for Malaria Venture (MMV) announced today that the Australian Therapeutic Goods Administration (TGA) accepted the submission of a Category 1 application to extend the indication of single-dose Kozenis (tafenoquine) to paediatric ...
WHO urges countries to “step up” the fight against malaria europeanpharmaceuticalreview
December 03, 2020
The WHO’s World malaria report suggests the progress in eradicating malaria has slowed due to funding shortages and that COVID-19 disruptions could result in additional deaths.
Why are children waiting so long for new meds? expresspharma
June 10, 2020
COVID-19 and drug resistance are threatening to derail the progress made against the HIV, malaria and TB epidemics, and this may have a negative impact on child healthcare: Access to Medicine Foundation.
Amivas Announces FDA Approval of Artesunate for Injection for Severe Malaria americanpharmaceuticalreview
June 02, 2020
Amivas announced Artesunate for Injection 110 mg, powder and solvent for solution has received marketing approval by the US Food and Drug Administration (FDA).

Previous page 1 2 3 4 5 6 7 Next page